R&D Drug repositioning to bring forgotten assets from shelves to... A problem very rarely spoken about is the treatments that are promising, but are not developed further.
Patients Partner Content The PM Society – Giving Back The PM Society is a not-for-profit organisation with 40 years of Giving Back.
News PM Society announces new Chair for 2024 The PM Society has appointed Dom Marchant, Chief Creative Officer at OPEN Health, as Chair, to succeed co-chairs Caroline Benson of Cuttsy + Cuttsy and Colin Williams from Astellas.
News PMV cues up filing for first p53-directed cancer therapy PMV is preparing to file for approval of its first-in-class oral p53 protein reactivator, rezatopopt, for ovarian cancer in the first quarter of 2027.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
